New Bill Targets Medical Price Regulation and Transparency

New Bill Targets Medical Price Regulation and Transparency

Read More
Full Text
last month

New Bill Targets Medical Price Regulation and Transparency



MP Ajeet Gopchade introduced the National Medical Pricing and Regulation Commission Bill, 2026, to address spiraling healthcare costs and out-of-pocket medical expenses in India. This proposed legislation establishes a framework for Medical Price Regulation across the country. The bill aims to create an independent commission empowered to fix, regulate, and oversee medical charges for all healthcare establishments. Consequently, this change will significantly impact the operations of private and public healthcare providers.



The Mandate for National Medical Price Regulation



Healthcare affordability in India has become a grave concern. Currently, the Clinical Establishments (Registration and Regulation) Act, 2010, provides for registration and minimum standards. However, it fails to establish a statutory authority for rationalizing medical charges. Therefore, hospitals and allied facilities levy widely divergent, non-transparent charges for similar services, diagnostics, and implants. These practices have resulted in financial hardship for patients. The proposed bill asserts that this undermines equitable access to healthcare. Furthermore, equitable access forms an integral component of the right to life under Article 21 of the Constitution.



How the Proposed Commission Will Function



The core of the bill is the establishment of the National Medical Pricing and Regulation Commission. A retired Supreme Court Judge will chair this independent body. Corresponding State and Union Territory Commissions will operate under the guidance of retired High Court Judges. The National Commission will frame, notify, and periodically revise national guidelines. Moreover, these guidelines will ensure rationalization, transparency, and standardization of medical and healthcare charges in both public and private sectors. For instance, the commission will prescribe principles and benchmarks for cost-based and value-based pricing. This ensures affordability, quality, and financial sustainability. The commission will also supervise compliance of the State and Union Territory Commissions.



Compliance, Penalties, and Refunds



Every healthcare establishment, including hospitals, clinics, and diagnostic centers registered under the Clinical Establishments Act, must mandatorily register with the respective State or Union Territory Commission. Consequently, these registered entities will pay an annual regulatory fee. This fee covers the administrative and enforcement expenses of the Commissions. Importantly, the bill sets out clear compliance measures. Establishments charging beyond the approved limits face monetary penalties. If caught overcharging, they must refund the excess amount to the patient with interest. Furthermore, repeated non-compliance could lead to the loss of a hospital's registration.



Frequently Asked Questions



Q1: What is the main purpose of the National Medical Pricing and Regulation Commission Bill, 2026?


The main purpose is to establish an independent body that can fix, regulate, and oversee medical charges to increase fairness, transparency, and affordability in healthcare and curb spiraling out-of-pocket expenses for patients.



Q2: Which healthcare entities must register with the new commission?


Every hospital, nursing home, clinic, diagnostic center, and allied healthcare establishment registered or required to be registered under the Clinical Establishments (Registration and Regulation) Act, 2010, must mandatorily register with the respective State or Union Territory Commission.



Q3: What are the penalties for overcharging under the proposed bill?


Establishments charging beyond approved limits are liable to monetary penalties. They must also refund the excess amount to the patient with interest. Serious or repeated wrongdoing may lead to the hospital losing its registration.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.


References



  1. MP Ajeet Gopchade moves bill to regulate medical prices - ETHealthworld

  2. India's Healthcare Cost Trap: How Excesses, Overtreatment and Weak Regulation Inflate Medical Bills - Deccan Herald

  3. West Bengal Assembly passes Bill on 'transparency' in medical costs in private facilities - The Hindu

Login to continue

More from MedShots Daily

New Bill Targets Medical Price Regulation and Transparency
New Bill Targets Medical Price Regulation and Transparency

MP Ajeet Gopchade proposed the National Medical Pricing and Regulation Commission Bill, 2026, creating a commission to fix and regulate medical prices for t...

last month

Read More
Full Text
Kallistatin's Role in Myosteatosis and Exercise Intolerance Revealed
Kallistatin's Role in Myosteatosis and Exercise Intolerance Revealed

New study finds elevated Kallistatin drives muscle fat accumulation and exercise intolerance by antagonizing AdipoR1-mediated AMPK signalling....

Today

Read More
Full Text
Grip Strength in Early Pregnancy: A Simple Predictor for Hypertensive Disorders?
Grip Strength in Early Pregnancy: A Simple Predictor for Hypertensive Disorders?

A large cohort study finds that higher grip strength in early pregnancy is linked to a significantly lower risk of hypertensive disorders like preeclampsia....

Today

Read More
Full Text
Advancing Pulmonary Hypertension Therapy: Inhaled Riociguat Pharmacokinetics
Advancing Pulmonary Hypertension Therapy: Inhaled Riociguat Pharmacokinetics

A mouse study comparing solution and suspension dosing suggests inhaled riociguat provides sustained lung exposure, potentially improving PH management....

Today

Read More
Full Text
Zoledronate Outperforms Denosumab in Initial Protection Against Vertebral Fractures
Zoledronate Outperforms Denosumab in Initial Protection Against Vertebral Fractures

A cohort study reveals that zoledronate provides better initial protection against vertebral fractures than denosumab in treatment-naive osteoporosis patien...

Today

Read More
Full Text
Linking Depressive Symptoms and Stroke Risk in CKM Syndrome
Linking Depressive Symptoms and Stroke Risk in CKM Syndrome

This study demonstrates that higher depressive scores significantly increase the risk of stroke across all stages of cardiovascular-kidney-metabolic syndrom...

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris